Literature DB >> 21108676

Quality of life, anxiety and depression in ALS patients and their next of kin.

Anneli G Olsson Ozanne1, Susann Strang, Lennart I Persson.   

Abstract

AIM AND
OBJECTIVES: The aims were to study health-related quality of life, anxiety and depression in patients with amyotrophic lateral sclerosis and their next of kin and to compare these results with a subset of the general Swedish population. Thirty-five pairs of patients with amyotrophic lateral sclerosis and their next of kin were studied.
BACKGROUND: Life changes in many ways when a person is diagnosed with amyotrophic lateral sclerosis. Comparison between patients, next of kin and the general population are needed to get a wider understanding of their quality of life, anxiety and depression.
DESIGN: A descriptive study.
METHODS: All participants were studied with the SF-36 and the Hospital Anxiety and Depression Scale. Patients' physical function was assessed by the amyotrophic lateral sclerosis Functional Rating Scale-Revised and the Norris scale.
RESULTS: A correlation was found in both the mental component summary in SF-36 and in anxiety between the pairs of patients and their next of kin, while no correlation was found in the physical component summary or depression. These results were not related to the patients' physical function. Both patients and their next of kin had some poorer ratings in SF-36 and in anxiety and depression than the general Swedish population. Gender or age did not affect the estimates in any of the scales.
CONCLUSIONS: The results indicate that both the patient and the next of kin are affected by the disease independent of physical disability. In most pairs of patient and next of kin, the mental component summary and anxiety were affected to a similar extent. RELEVANCE TO CLINICAL PRACTICE: The results emphasise the need for medical and nursing support to both the patient and the next of kin soon after the diagnosis and during the course of the disease.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108676     DOI: 10.1111/j.1365-2702.2010.03509.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Depression in amyotrophic lateral sclerosis.

Authors:  Elin Roos; Daniela Mariosa; Caroline Ingre; Cecilia Lundholm; Karin Wirdefeldt; Per M Roos; Fang Fang
Journal:  Neurology       Date:  2016-04-22       Impact factor: 9.910

2.  Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.

Authors:  Qianqian Wei; Zhenzhen Zheng; Xiaoyan Guo; Ruwei Ou; Xueping Chen; Rui Huang; Jing Yang; Huifang Shang
Journal:  Neurol Sci       Date:  2016-01-13       Impact factor: 3.307

3.  Emotional distress and well-being among people with motor neurone disease (MND) and their family caregivers: a qualitative interview study.

Authors:  Cathryn Pinto; Adam W A Geraghty; Lucy Yardley; Laura Dennison
Journal:  BMJ Open       Date:  2021-08-17       Impact factor: 3.006

Review 4.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

5.  Family caregivers' accounts of caring for a family member with motor neurone disease in Norway: a qualitative study.

Authors:  Sverre Vigeland Lerum; Kari Nyheim Solbrække; Jan C Frich
Journal:  BMC Palliat Care       Date:  2016-02-24       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.